According to health authorities, the world's first confirmed case of multidrug-resistant gonorrhea has been reported in the UK
Health professionals have been concerned for some time about the rise of drug-resistant strains of the reproductive organs (STI). Even if gonorrhea strains avoid certain antibiotics, doctors can usually treat the disease with a combination of commonly used drugs – until now.
The British patient – a heterosexual man reporting from a regular female sexual partner The United Kingdom and one in Southeast Asia about a month before the onset of symptoms – has the world's first confirmed case of gonorrhea, which is resistant to both drugs commonly used to treat it, according to a case report from the UK Health Department. His illness has responded to either azithromycin, an antibiotic commonly used for gonorrhea, or ceftriaxone, which the World Health Organization (WHO) refers to as "the final treatment." He was also treated with the antibiotic Spectinomycin. 1
The patient, who first sought medical help Care in early 2018, is being treated with an intravenous course of ertapenem, a potent antibiotic usually used, at least in the US, for "serious infections in hospitalized patients," according to the National Institutes of Health. The results of his next test are expected in mid-April.
Gonorrhea is one of the most prevalent sexually transmitted diseases in the world and, according to the WHO, affects 78 million people worldwide each year. The condition – complications that can cause pelvic inflammation, ectopic pregnancy, infertility, and an increased risk of HIV infection – is also common in the US. A September report from the Centers for Disease Control and Prevention estimated that 470,000 Americans were diagnosed with gonorrhea in 2016 alone – the prospect of untreatable strains all the more worrying.